Life Technologies to Collaborate with Boston Children’s Hospital to Develop an Optimized Lab Workflow based on the Ion Proton™ Sequencer

Life Technologies Corporation and Boston Children’s Hospital, home of the world’s largest pediatric research enterprise, today announced a research and development collaboration to develop an end-to-end genetic sequencing lab workflow based on Life Technologies’ Ion Proton™ Sequencer. The parties plan to collaborate and develop an optimized laboratory infrastructure and lab protocols for an advanced sequencing facility to be built at Boston Children’s in compliance with CLIA and CAP certification standards.

Please to read the entire article.